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Objective: to assessed the prevalence of diabetes mellitus (DM) and drug abuse in mothers of 
children with orofacial clefts (OFC). Methods: 325 women who had children (0-3y) with clefts 
were interviewed. Data regarding type of diabetes, use of legal/illegal drugs during pregnancy, 
waist girth and fasting blood sugar at the first prenatal consult were collected. Results: twenty 
seven percent of the women had DM, out of these, 89% had gestational DM, 5,5% type 1 DM 
and 5,5%  type 2 DM. The prevalence of DM in mothers of children with OFC was 27%, it is 
significantly higher than the average Brazilian population which is 7.6% (p<0.01) (OR=4.5, 
95%CI=3.5-5.8). Regarding drug abuse during pregnancy, 32% of the mothers used drugs and a 
significant positive correlation was observed between drug abuse and the occurrence of clefts and 
other craniofacial anomalies (p=0.028) (OR=2.87; 95%CI=1.1-7.4). Conclusions: DM and drug 
abuse during pregnancy increases the risk for OFC and related anomalies and early diagnosis of 
DM and prevention of drug abuse, especially in pregnant women, should be emphasized.
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Introduction
Diabetes mellitus (DM) is a metabolic disease 
resulting in hyperglycemia, either because of the low 
insulin levels or due to insulin resistance. According 
to the World Health Organization (WHO) definition, 
metabolic syndrome is significantly associated with age, 
physical activity, dyslipidemia, hypertension, treatment 
with oral antihyperglycemic medication, and HbA1c 
levels >7%(1).
The global prevalence of DM for all ages was 
estimated to be 8,3% and is projected to almost double 
in 2035(2), even in low and middle-income countries such 
as Brazil(3). Data obtained by the Brazilian government 
show that the prevalence of DM in the adult population 
was 6.3%(4).
Gestational diabetes mellitus (GDM) is defined as 
a carbohydrate intolerance initially diagnosed during 
pregnancy. Author(5) stated that the pregnancies of 
women who were both obese and diabetic were 3 times 
as to result in an offspring with a craniofacial defect than 
were those of nonobese, nondiabetic women, suggesting 
that obesity and diabetes mellitus contributes in the 
pathogenesis of congenital anomalies.
The assumption that GMD is associated with 
increased occurrence of syndromes and malformations 
might be attributed to the deleterious effect of 
hyperglycemia in the early stage of pregnancy. This 
indicates that poor glycemic control during pregnancy 
increases the risk of congenital defects(6). However, it 
is still controversial as to whether --- severe levels of 
hyperglycemia are associated with higher risk of adverse 
events during pregnancy.
As well as hyperglycemia, drug abuse (DU) 
during pregnancy represents a high risk behavior for 
the occurrence of several congenital malformations 
including orofacial clefts(7) and represents one of the 
most significant social problems around the world(8).
Congenital anomalies are extremely variable 
regarding the type as well as the causes. Orofacial clefts 
(OFC) are functional and structural malformations as 
a result of an abnormal development of the maxillary 
complex during embryogenesis and can be characterized 
by the lack of continuity of the upper lips, upper alveolar 
ridge and palate and can affect these structures partially 
or completely(9). 
The etiology of OFC is complex and multifactorial. 
Genetic factors, environmental factors and the interaction 
of both may interfere with the intrinsic mechanism 
of pregnancy causing embryological abnormalities. 
Mutations in IRF6 , MSX1, FOXE1, MTHFR C677T, FAF1 
and TGFB genes represent the genetic factors(10-12). 
Among the environmental factors are maternal 
nutritional status (hypo- and hypervitaminosis), 
smoking and alcohol consumption during pregnancy, 
occupational exposures to chemicals (solvents and 
pesticides), exposure to X-rays, maternal illness during 
pregnancy including diabetes mellitus, epilepsy and viral 
infections, and the inadvertent use of some medications 
such as benzodiazepines and corticosteroids(13-16).
DM have shown that it represents a potential 
etiological factor for several anomalies, indicating that 
women with diabetes present higher chances of having 
children with congenital anomalies, including OFC(14). 
However, no data from the Brazilian population was 
found in the literature. 
The Hospital for Rehabilitation of Craniofacial 
Anomalies is a Brazilian public Hospital located in the 
centre of the São Paulo State and is recognized by the 
World Health Organization as a world reference center 
for the treatment of cleft lip and palate and related 
anomalies. HRAC is a tertiary hospital and the fundings 
for the treatment of the 100.000 patients registered come 
from the University of São Paulo and from the Brazilian 
health public system. People from all over Brazil can be 
registred at HRAC, independently of their social status. 
Therefore, this study assessed the prevalence of DM and 
DU in mothers of children born with OFC in the Hospital 
for Rehabilitation of Craniofacial Anomalies – University 
of São Paulo (HRAC/USP), Brazil, and compared it with 
that of a background Brazilian population.
Method
This study was approved by the IRB of HRAC/USP. 
The sample size for this study was calculated based on 
data showing that the prevalence of diabetes in Brazil is 
between 6% and 8%(3-4) and a number of 324 individuals 
was reached. 
This was a cross-sectional observational study, 
with data collected during a time interval of 12 months, 
until a number of 325 women and their offspring born 
cleft lip and palate (CLP) was reached. Participants were 
recruited as follows: the interviewer was introduced to 
the mothers by the physician responsible for the first 
appointment or by one of the nurses that comprise the 
multidisciplinary team of the HRAC/USP. The purposes of 
the study were explained to them and only mothers who 
agreed to participate and signed the informed consent 
form were enrolled in the study. Considering that the 
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HRAC/USP is a hospital for the exclusive treatment of 
individuals with CLP, all women evaluated in the present 
study have had children with CLP.
Data was collected on a private room by one 
the authors of the present study, a nurse trained for 
the application of the questionnaire. All children were 
followed up at HRAC/USP. Mothers were examined and 
the results from the fasting glucose test (level of glucose 
during pregnancy expressed in mg/dL) were collected 
by recording data from the first pre-natal exam. 
Abdominal circumference was assessed and measures 
>80cm were considered as an indicative of obesity(17). 
In addition to the clinical data, a questionnaire with 24 
questions was given to the mothers and they answered 
questions regarding the type of diabetes (Type 1, Type 2 
or Gestational) and any other comorbidities associated 
with the disease. Women were also asked to answer 
questions regarding history of hypertension, obesity, 
use of legal and illegal drugs during pregnancy, and 
any lists of medication. Drug categorization into licit 
or illicit followed the United Nations Office on Drugs 
and Crime - UNODC classification (2015), which states 
that the term illicit drugs describes drugs which are 
under international control (and which may or may not 
have licit medical purposes) but which are produced, 
trafficked and/or consumed illicitly. Among the most 
consumed licit use drugs worldwide are alcohol and 
tobacco, while cannabis, cocaine and crack represent 
the most common illicit use drugs(18).
Data regarding age, race, educational level and 
symptoms related to DM were also collected. Educational 
level was ranked according to The International Standard 
Classification of Education , ISCED - 2011, from the United 
Nations Educational, Scientific and Cultural Organization – 
UNESCO(19), as follows: 1) primary education (fundamental 
skills in reading, writing and mathematics), 2) lower 
secondary education (based on primary education, with 
a more subject-oriented curriculum), 3) upper secondary 
education (final stage of secondary education preparing 
for tertiary education and/or providing skills relevant to 
employment), 4) post-secondary non-tertiary education 
(learning experiences that prepare for labour market 
entry and/or tertiary education), and, 5) bachelor / 
tertiary education (programmes designed to provide 
intermediate academic and/or professional knowledge, 
skills and competencies leading to a first tertiary degree 
or equivalent qualification).
Proportions were compared by calculating the rate 
difference and its 95% CI (confidence interval). One way 
Analysis of Variance test and the Student´s t test were 
used to assess the possible effects of glucose level and 
maternal age in determining different types of clefts and 
related anomalies, respectively. Chi-Square test and 
Fisher exact test were used to determine the significance 
of the association between the use of licit and illicit drugs 
and the type of cleft and related anomalies, respectively. 
Results were assessed by the Statistica software. A p 
value of < 0.05 was considered statistically significant.
Results
The mothers ranged in age from 15 to 50 years 
old, with a mean age of 29 years old, while the children 
ranged in age from 0 to 3 years. The majority of women 
had completed middle school 155 (48%). Regarding 
race, 177 (55%) self-reported as white and 141 (43%) 
as black or of Afro-descendant. Regarding clinical 
symptoms of DM, 165 (51%) of the mothers reported 
feeling tired and lethargic early in the morning, 143 
(44%) reported postpartum weight loss and 140 (43%) 
reported asthenia, as seen on Table 1.
Table 1 – Distribution of the women population regarding 
age, race, educational level and symptoms related to 
diabetes mellitus (DM). Bauru-SP, Brasil, 2012.
Variables N %
AGE
15 - 20 36 11.1
21 - 30 157 48.3
31 - 40 117 36.0
41 - 50 15 4.6
RACE*
WHITE 177 54.5
AFRICAN-DECENT 111 34.2
BLACK 30 9.2
ASIAN 04 1.2
NATIVE INDIAN 03 0.9
EDUCATIONAL LEVEL†
ILLITERATE 02 0.6
PRIMARY EDUCATION 114 35.1
LOWER SECONDARY EDUCATION 155 47.7
UPPER SECONDARY EDUCATION 52 16.0
TERTIARY EDUCATION 02 0.6
SYMPTOMS OF DM‡
WEIGHT LOSS 143 12.5
ASTHENIA 140 12.2
POLYPHAGIA 124 10.8
POLYDIPSIA 123 10.7
POLYURIA 95 8.3
TOTAL (N) 325 100
*Criteria adopted by IBGE for race (Brazilian Government); 
†The International Standard Classification of Education (ISCED) - 2011, 
from the United Nations Educational, Scientific and Cultural Organization 
(UNESCO); ‡DM: diabetes mellitus
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From the 325 women who answered the 
questionnaire, 28 came to the HRAC hospital already 
with the diagnosis of DM. From the remaining 297 
women, 60 presented with pre-natal glycemic levels 
≥ 92 mg/dL at the first consult with the obstetrician. 
Therefore, following the criteria of the American Diabetes 
Association and the International Diabetes Federation, 
they were added to the initial 28 women with a previous 
diagnosis of DM, resulting in 88 women with DM (27%). 
Out of these 88 women, 78 were diagnosed with GDM 
(89%), 5 with type 1 (5,5%) and 5 with type 2 DM 
(5,5%) (Table 2). This finding is significantly higher than 
the average Brazilian population which is around 7%(3-4) 
(p<0.01).
Table 2 – Distribution of women who gave birth to children with OFC in the study. Bauru-SP, Brasil, 2012.
Diagnostic n % 95% Confidence Interval including continuity correction
DM* 88† 27 22.39 32.07
GDM‡ 78 24 19.50 28.81
DM1§ 5 1.5 0.29 3.09
DM2|| 5 1.5 0.29 3.09
*DM: diabetes mellitus; †(p<0,01) in relation to the general population (prevalence of Brazilian women with DM), ‡GDM: gestational diabetes mellitus, 
§DM1: type 1 diabetes mellitus; ||DM2: type 2 diabetes mellitus
From the total of 88 women with a diagnosis of DM, 
all factors that could contribute to the development of 
congenital anomalies such as consumption of alcohol, 
smoking, use of illegal drugs or potential teratogenic 
medications as well as patients with obesity, high blood 
pressure or dyslipidemia were excluded. This resulted 
in 52 women (16%) being diagnosed with maternal 
hyperglycemia as the isolated causal factor for congenital 
anomalies, including orofacial cleft (Figure 1).
Figure 1 – Process of identification of mothers with Diabetes Mellitus
325 children
 with OFC*
52 (16%)
 mothers with 
DM† + CF‡
88 (27%) 
mothers 
with DM†
237 (73%) 
mothers 
without DM†
78 (89%) 
mothers with GDM§
5 (5.5%) 
mothers with DM1ǁ
5 (5.5%) 
mothers with DM2¶
* OFC: orofacial clefts; †DM: diabetes mellitus; ‡CF: confounding factors (alcohol consumption, smoking or use of medications or legal/ illegal drugs during 
pregnancy, obesity and high blood pressure); § GDM: gestational diabetes mellitus, ǁDM1: type 1 diabetes mellitus; ¶DM2: type 2 diabetes mellitus. 
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The odds ratio of hyperglycemic mothers including 
confounding factors/global prevalence of DM was 4.5 CI 
(3.5 to 5.8) (n=88) and the odds ratio of hyperglycemic 
mothers excluding confounding factors/global prevalence 
of DM was 2.3 CI (1.7 to 3.1) (n=52). 
The level of glucose and maternal age during 
pregnancy and their relations with the type of cleft and 
related anomalies are presented in Table 3. It can be 
seen that the greater the level of glucose, the severe 
is the type of cleft. For example, mothers who gave 
birth to children with CLP had a mean level of glucose 
of 169mg/dL while mothers who gave birth to children 
with cleft lip had a mean level of glucose of 117mg/
dL However, no significant differences were observed. It 
was also observed that increasing age is associated with 
the severity of the cleft type and with the presence of 
related anomalies. In other words, older mothers gave 
birth to children with more severe clefts and with related 
anomalies associated to CLP, such as Pierre Robin 
sequence, hand and feet malformations, hydrocephalus 
and Down syndrome, among others. Yet again, no 
significant differences were observed.
Table 3 - Level of glucose during pregnancy and maternal age and their relations with the type of cleft and related 
anomalies. Bauru, SP, Brasil, 2012.
Level of glucose during pregnancy (mg/dL)
Maternal age during pregnancy
N x±sd
Type of cleft
CL* 117.44±20.34 9 30.11±7.25
iCP† 143.33±64.63 33 21.18±6.42
CLP‡ 169.27±126.79 45 30.33±6.32
Related anomalies
Presence 160.39±119.95 44 31.00±6.38
Abscence 147.61±76.88 43 30,26±6.45
*CL: cleft lip; †iCP: isolated cleft palate; ‡CLP: cleft lip and palate / no significant differences observed; 
Results showed that 28 women (32%) of the 
present sample used drugs during pregnancy. From 
these, 64% of their offspring had complete CLP, i.e, the 
most severe type of cleft. This number decreased to 46% 
in mothers who have not used drugs during pregnancy. 
However, differences were not statistically significant. 
Moreover, a particular data stands out, 69% of the 
offspring of mothers who used drugs during pregnancy 
was born with CLP associated to other craniofacial 
anomalies while only 42% of the children was born with 
the same characteristics from mothers who haven’t used 
drugs during pregnancy (Table 4). This difference was 
statistically significant (p=0.028). It was also observed 
an increased odds of having a child with CLP and with 
related anomalies among women who used drugs during 
pregnancy (OR=2.87; 95% CI=1.1-7.4).
Table 4 - Licit and illicit drug abuse during pregnancy and its relation with the type of cleft and related anomalies. 
Bauru-SP, Brasil, 2012.
Drug abuse in pregnacy
Licit drug in 
Pregnancy
Illicit drug in pregnacy
Yes No Yes No Yes No
n(%) n(%) n(%)
Type of cleft
CL* 2(7%) 7(12%)
iCP† 8(29%) 25(42%)
CLP‡ 18(64%) 27(46%)
Related anomalies
presence 20(69%)§ 25(42%) 19(68%)|| 26(43%) 3(75%) 41(49%)
abscence 9(31%) 34(58%) 9(32%) 34(57%) 1(25%) 42(51%)
 
*CL: cleft lip; †iCP: isolated cleft palate; ‡CLP: cleft lip and palate   §p=0.028; ||p=0.030
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Considering this important data regarding the 
use of drugs and the occurrence of other craniofacial 
anomalies associated to CLP, an attempt to differentiate 
the effects of licit and illicit drugs in the fetus was 
done (Table 4). Results have shown that there is a 
positive correlation between the use licit drugs in the 
periconceptional period and the occurrence of related 
craniofacial anomalies (p=0.03). This correlation was 
not observed for the illicit drugs
Discussion
The current study shows that women with 
diabetes mellitus are more likely to have children with 
orofacial clefts when compared to women without 
DM. The prevalence of DM in the sample analyzed 
was 27% while on the global and in the Brazilian 
populations this percentage is significantly lower, of 
around 7%(3-4). The study also shows that drug abuse 
during pregnancy increases in almost 3 times the risk 
for the occurrence of orofacial clefts associated with 
other craniofacial anomalies. 
Due to the high prevalence of DM in this population, 
the comorbidities associated with congenital anomalies 
were excluded to assess exclusively maternal 
hyperglycemia as a possible causal factor of OFC. 
Thus, factors such as consumption of legal or illegal 
drugs during the gestational term were excluded(20-21). 
Women with abdominal circumferences >80cm 
were considered obese and were not included in the 
second analysis(17). Hypertension and dyslipidemia 
were additionally excluded, because these clinical 
conditions are commonly associated with diabetes 
and represent risk factors for the development of 
metabolic syndrome(22-23). Women that were treated 
with antibiotics, anti-hypertensive, anti-emetics, non-
steroid anti-inflammatories, anticonvulsant, corticoids 
and other types of analgesics were also excluded from 
the analysis since the use of these medications during 
pregnancy could be a factor for the development of 
OFC(15-16). It is important to mention that the majority 
of women reported that they have had supplements 
of folic acid (58%), iron (59%), and multi-vitamins 
(23%) during the gestational period for prevention of 
congenital anomalies.
Therefore, when the comorbidities during 
pregnancy previously mentioned were excluded, the 
prevalence of DM dropped to 16%, however it still 
represents more than twice the percentage of DM in 
the global population. In other words, it is possible to 
infer that hyperglycemia during pregnancy increases 
the risk for the occurrence of OFC. These results are 
in accordance with the findings of other study(24) that 
have mentioned that maternal diabetes can induce 
congenital malformations in laboratory animals and 
in humans, including facial deformities and defects in 
neural tube closure. These authors have also stated 
that the incidence of birth defects in newborns of 
women with diabetes is approximately 3–5 times 
higher than among women without diabetes.
The findings presented in this study reinforce the 
need for rigorous control of DM during the gestational 
period. Among women with DM (n=88) from this 
sample, 60 (68%) did not have any control of glycemic 
levels during gestation, suggesting that these fetuses 
were exposed to maternal hyperglycemia during 
embryogenesis. This poor glycemic control is probably 
due to the low social status of this population. 
Regarding their educational level, the majority of 
them completed middle school and in some cases, 
they reported that the birth of a child with a congenital 
anomaly forced them to stop studying to take care of 
the child. There are also reports from those mothers 
of anxiety and depression when they were surprised 
with the information that their children were diagnosed 
with some type of congenital anomalie(25).
The authors believe that the number of women 
with diabetes could be even higher, since the 
information about the glycemic test was not conducted 
prospectively as part of the study, and there is no 
information about the conditions in which the glycemic 
test was performed. Many of the women on this study 
live far from the centers where the blood was drawn. 
Ideally, the glycemic test should be performed after a 
fasting period of at least 8 hours and no longer than 
14 hours. 
The primary objective of this study was to 
investigate the prevalence of diabetes mellitus in 
mothers of children with CLP. However, during data 
collection, an important finding has emerged. Among 
the group of mothers who referred using drugs during 
pregnancy, 69% of children were born with orofacial 
clefts and with other congenital anomaly, whereas 
in the group of mothers who did not use drugs, the 
percentage of children with orofacial clefts associated 
with other anomalies was significantly lower (42%). 
This means that mothers who use drugs during 
pregnancy have nearly 3 times more likely to have 
a child with CLP associated with other congenital 
anomalies than the mothers from this sample who 
have not used drugs during pregnancy. Pierre Robin 
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Sequence (9%) was the most prevalent congenital 
malformation observed, followed by cardiopathies 
(5%), foot and hand malformation (3%), hearing 
issues (1%) and other syndromes. 
Regarding the type of drug abused, it has been 
shown that the use of licit drugs such as alcohol, 
tobacco, benzodiazepines, stimulants, anticonvulsants 
and other antidepressants increase the risk for the 
occurrence of other congenital anomalies together with 
CLP. This positive correlation could not be observed 
for the illicit drugs, such as cocaine and cannabis, 
probably because of the small sample size. It is 
important to mention that the concern of assuming an 
illegal behavior may have underestimated the number 
of mothers who used drugs during pregnancy.
The results of this study highlight that prevention 
campaigns to drug abuse should also focus on the 
pregnant population whose condition, unfortunately, 
do not keep them free from the use of licit or illicit 
chemical substances during pregnancy. The study also 
highlights the importance of glycemic control for early 
detection of hyperglycemia, even before conception 
and especially in pregnant women. If not detected 
and treated, hyperglycemia could lead to congenital 
anomalies. DM and DU could also result in physical, 
psychosocial and economic problems for families and 
society as well as increasing costs for the health care 
system.
More prospective studies should be conducted 
to evaluate the prevalence of DM and DU in mothers 
of children born with OFC. Thus, the association 
between the severity of the DM, its relationship to 
the gestational term, and the type of clefts observed 
could be studied. Ideally, the focus should be in 
preventing these congenital anomalies through early 
diagnosis of DM and prevention of DU. In addition, a 
multidisciplinary approach should be developed, which 
could lead to more comprehensive care and could 
minimize the development of different congenital 
anomalies.
Conclusion
It can be concluded that hyperglycemia and drug 
abuse during pregnancy increases the risk for occurrence 
of OFC and related anomalies and, consequently, early 
diagnosis of DM and prevention of DU, especially in 
pregnant women, should be emphasized.
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